US-guided 14-gauge Core-Needle Breast Biopsy: Results of a Validation Study in 1352 Cases

US-guided 14-gauge Core-Needle Breast Biopsy: Results of a Validation Study in 1352 Cases
Gerd Schueller, Sylvia Jaromi, Lothar Ponhold, Michael Fuchsjaeger, Mazda Memarsadeghi, Margaretha Rudas, Michael Weber, Laura Liberman, and Thomas H. Helbich
Radiology 2008;248 406-413

Link to Journal

We found agreement among US-guided 14-gauge core-needle breast biopsy results, surgical excision histologic findings, and clinical and imaging follow-up results of 95.8%, with a false-negative rate of 1.6%

Detecting Nonpalpable Recurrent Breast Cancer: The Role of Routine Mammographic Screening of Transverse Rectus Abdominis Myocutaneous Flap Reconstruct

Detecting Nonpalpable Recurrent Breast Cancer: The Role of Routine Mammographic Screening of Transverse Rectus Abdominis Myocutaneous Flap Reconstructions
Janie M. Lee, Dianne Georgian-Smith, G. Scott Gazelle, Elkan F. Halpern, Elizabeth A. Rafferty, Richard H. Moore, Eren D. Yeh, Helen A. D'Alessandro, Rachel A. Hitt, and Daniel B. Kopans
Radiology 2008;248 398-405

Link to journal

With routine screening mammography, the detection rate of recurrent nonpalpable cancer in transverse rectus abdominis myocutaneous flap breast reconstructions, over a median follow-up period of 4.9 years, was 0%

Breast US Computer-aided Diagnosis Workstation: Performance with a Large Clinical Diagnostic Population

Breast US Computer-aided Diagnosis Workstation: Performance with a Large Clinical Diagnostic Population
Karen Drukker, Nicholas P. Gruszauskas, Charlene A. Sennett, and Maryellen L. Giger
Radiology 2008;248 392-397

Link to Journal

The computer performance was largely unaffected by the inclusion of large numbers of lesions that did not undergo biopsy in the analysis, achieving overall good lesion characterization performance at area under the receiver operating characteristic curve value of 0.90